Skip to main content

GET INVOLVED STUDIES 7207 Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact)



Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact)


In order to participate in a study, you must personally contact the
APF Edrin 1-866-APF-3635

Status: Recruiting

Background

The Erythropoietic Protoporphyrias include EPP and XLP. (Together they are the third most common porphyria and the most common in children.
The purpose of this study is to learn more about EPP and XLP and how to better treat people with them.
Researchers will observe participants over several years to learn about:
  1. How often certain signs that indicate how bad the disease is occur as they are related to skin symptoms. For example, levels of protoporphyrins effects on the liver and other tissues affected by erythropoietic protoporphyrias.
  2. What are the psychosocial effects of living with EPP/XLP.
This is a longitudinal study (study taking place over 5 years) of about 150 individuals with EPP. Participants enrolled in this study should also be enrolled in the Longitudinal Study of the Porphyrias. Those participating in this study will be evaluated yearly. If possible, the first study visit should happen at one of the Porphyrias Consortium clinical sites (see the list of participating sites below).
Participation in this study will involve the following:
  1. Accessing the information that you provided for the “Longitudinal Study of the Porphyrias”, including the results of the physical examinations, medical history, family history, questionnaires, and the results of laboratory tests;
  2. Review of your medical records at each study visit; the study doctor may request medical records in between study visits to see how you are doing or if there is a medical concern that may be related to your porphyria or to the study;
  3. Collection of samples, including:
    • blood (about 2-4 tablespoons)
    • urine (about ¼ cup) for testing and storage.
  4. Completion of quality of life questionnaires
Testing on these samples may include measurement of certain products found in the blood and urine of people with porphyria and DNA analysis to find the mutation (or change) in the porphyria gene that is causing your porphyria. These samples will be collected at your first study visit, however, we may ask for additional samples later.

Targeted Enrollment

To be eligible to participate, you must:
You are not eligible to participate if you have:
  • You have elevations of porphyrins in urine, plasma or erythrocytes due to other diseases (i.e. secondary porphyrinuria or porphyrinemia), such as liver and bone marrow diseases.
  • A prior diagnosis of porphyria that cannot be documented by review of existing medical records or repeat biochemical or DNA testing.

Comments

Popular posts from this blog

Amazing patient advocacy....and needed media for this issue. Thank you Terri Witter!

WHAT IS NEUROPATHIC PAIN?

What could it be?
Nerve Pain WHAT IS NEUROPATHIC PAIN? Neuropathic or nerve pain (NP) is a long-term or chronic pain disease that results from nerve damage. It can be caused by different diseases or conditions. Worldwide nerve pain affects as many as 26 million people. Neuropathic or nerve pain may affect larger areas of the body or it can be restricted to a smaller area, in this case it is called localized neuropathic pain (LNP). WHAT CAUSES NEUROPATHIC PAIN? Neuropathic or nerve pain may occur in the absence of an obvious visible cause (e.g. an accident, an injury, a chemical burn). There are several external situations that can directly damage nerves and lead to neuropathic pain, such as: Amputation of a limb (phantom pain, stump pain)Surgery (scar pain, post-surgery pain)Trauma or accident Neuropathic pain is also a common complication of other diseases, including nerve damage after shingles or herpes zoster infection (postherpetic neuralgia or PHN), nerve damage after HIV infectio…

GLOBAL PORPHYRIA ALLIANCE

GLOBAL PORPHYRIA ALLIANCE The APF is proud to support our members that live across the globe. Many countries around the world have developed organizations to support their local communities. We hope that enjoy the same opportunity to communicate with one another, develop friendships, and learn about porphyria. Here are links to patient advocacy groups worldwide that offer support to individuals impacted by porphyria. Argentina: Centro de investigaciones sobre porfirinas y porfirias | More informationAustralia: Porphyria Association, Inc. | More informationBrazil: Associação Brasileira de Porfiria | More informationCanada: Canadian Association for Porphyria | More informationColombia: Fundación Colombiana Para La Porfiria | More informationDenmark: Porfyriforeningen.dk (Porphyria Association Denmark)Denmark: Porfyrier.dk (Danish Porphyria Support Group)England: British Porphyria AssociationFinland: Finnish Porphyria Support Group France: Association Française des Malades Atteints de Por…